Police Commissioner Mohit Agarwal said the Special Investigation Team (SIT) has traced assets worth around Rs 38 crore belonging to Shubham Jaiswal, who is under a look-out notice, and his family and placed the findings before the court.
"Based on this, the court issued a notice seeking details of the properties within a week," Police Commissioner Mohit Agarwal told PTI.
If the required details are not given within the stipulated time, the properties will be sealed, Agrawal added.
Under the law, any asset that is acquired through criminal activities can be seized during the course of the investigation itself, he said.
The SIT is examining diversion of medicines, financial transactions and links among the accused, with officials citing evidence of super-stockists and cross-border trafficking to Nepal and Bangladesh.
Chief Minister Yogi Adityanath, during the assembly session on Monday, had said that the cases related to the illegal diversion of syrup are being taken up under the Narcotic Drugs and Psychotropic Substances Act.
Adityanath had clarified that codeine-based syrup is not manufactured in Uttar Pradesh, and the state only has stockists and wholesalers. Production takes place in states like Himachal Pradesh and Madhya Pradesh.
The death cases that came to light were reported from other states and were linked to a syrup manufactured in Tamil Nadu, he said.
Calling the matter one of illegal diversion, not adulteration, the chief minister said wholesalers from districts including Saharanpur, Ghaziabad, Varanasi, Lucknow and Kanpur were involved in diverting the syrup to states and countries where prohibition exists, leading to its misuse.
The state government had registered 79 cases, named 225 people and arrested 78 accused, while raids have been conducted at 134 firms, he said.
Uttar Pradesh Police is probing an alleged illegal network involved in the storage and distribution of highly regulated codeine-laced cough syrups across the state.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.